
Novartis has announced that it will expand its current partnership with Pear Therapeutics, signed in March, as it reveals that …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

